The IL-17 pathway-mediated immune cascade response plays a key role in the pathogenesis of psoriasis, e.g., lowering effector IL-17C expression reduces infiltrating immune cells and thus inhibits skin inflammation [33,34]. Here, IL17A is linked to dermatitis.